18-F-Bi-PSMA

N/A

Report date: 2025/11/06 17:59:39
NME

Base Information

Drug Name18-F-Bi-PSMA
Drug Alias Name18-F-Bi-PSMA
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionAnti-PSMAPositron-emission tomography enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsDiagnostic agentsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A